Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-γ binding agents

A compound selected from the group consisting of

• and pharmaceutically acceptable salts thereof.

A compound selected from the group consisting of

• and pharmaceutically acceptable salts thereof.

A compound selected from the group consisting of

• and pharmaceutically acceptable salts thereof.

A compound selected from the group consisting of

• and pharmaceutically acceptable salts thereof.

A compound selected from the group consisting of

• and pharmaceutically acceptable salts thereof.

A compound selected from:

• and pharmaceutically acceptable salts thereof.

A compound selected from the group consisting of:

• and pharmaceutically acceptable salts thereof.

A compound selected from:

• and pharmaceutically acceptable salts thereof.

A compound selected from:

• and pharmaceutically acceptable salts thereof.

A compound selected from:

• and pharmaceutically acceptable salts thereof.

A compound selected from:

• and pharmaceutically acceptable salts thereof.

A compound selected from:

• and pharmaceutically acceptable salts thereof.

A compound selected from:

• and pharmaceutically acceptable salts thereof.